본문 바로가기
KERD
논문KCI 등재

Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report

Dushad Ram|Shwetha Patil|Basavana Gowdappa|Iyshwarya Rajalakshmi
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2015.12|Clinical Psychopharmacology and Neuroscience|제13권 제3호|pp. 321-323

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Atomoxetine augmentTreatment resistant panic disorderSelective norepinephrine reuptake inhibitor

초록

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.

Abstract

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.

참고문헌 (14)

  1. Holt RL., "Management of treatment-resistant panic disorder", Psychiatry(Edgmont), 4, pp.48~59 (2007)
  2. Kessler RC., "The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 63, pp.415~424 (2006)
  3. Zamorski MA., "What to do when SSRIs fail : eight strategies for optimizing treatment of panic disorder", Am Fam Physician, 66, pp.1477~1484 (2002)
  4. Geller D., "Atomoxetine treatment for pediatric patients with attention-deficit", hyperactivity disorder with comorbid anxiety disorder, 2007, pp.46, 1119~1127
  5. Ravindran LN., "A randomized controlled trial of atomoxetine in generalized social anxiety disorder", J Clin Psychopharmacol, 29, pp.561~564 (2009)
  6. Christman AK., "Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder", Pharmacotherapy, 24, pp.1020~1036 (2004)
  7. Charney DS., "Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder", Arch Gen Psychiatry, 43, pp.1042~1054 (1986)
  8. Nesse RM., "Adrenergic function in patients with panic anxiety", Arch Gen Psychiatry, 41, pp.771~776 (1984)
  9. Bymaster FP., "Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat : a potential mechanism for efficacy in attention deficit", hyperactivity disorder, 2002, pp.27, 699~711
  10. Li WY., "Atomoxetine changes rat's HR response to stress from tachycardia to bradycardia via alterations in autonomic function", Auton Neurosci, 154, pp.48~53 (2010)
  11. Hajós M., "Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine", Naunyn Schmiedebergs Arch Pharmacol, 351, pp.624~629 (1995)
  12. Menezes GB., "Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder", Rev Bras Psiquiatr, 29(Suppl 2), pp.S55~S60 (2007)
  13. Yates WR., "Phenomenology and epidemiology of panic disorder", Ann Clin Psychiatry, 21, pp.95~102 (2009)
  14. Craske MG., "Panic disorder : a review of DSM-IV panic disorder and proposals for DSM-V", Depress Anxiety, 27, pp.93~112 (2010)

관련 논문AI추천

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018Antonio E. Nardi, Giampaolo Perna, Mariana C. Cabo, Morena M. Zugliani, Rafael C. Freire대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제1호Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant PatientIsa Naina-Mohamed, Mohamed S. Zulfarina, Razinah Sharif, Shuid A. Nazrun, Syed-Badrul Syarifah-Noratiqah대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제2호Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive DisorderEun Hyun Seo, Hyung-Jun Yoon, Jae-Hon Lee, Seung-Gon Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2023 · 제21권 제3호Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial김지선, 박원명, 심세훈, Heejung Yoon, Hyung Mo Sung, In Soo Heo, Jonghun Lee, Young Sup Woo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제1호The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting배치운, 이승훈, Ashwin A. Patkar, Changsu Han, Kyung Ho Lee, Prakash S. Masand, Soo-Jung Lee, Tae Sun Han, Won-Myong Bahk대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2024 · 제22권 제2호Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case ReportsAlessandro Valchera, Antonio Ventriglio, Domenico De Berardis, Federica Vellante, Giovanni Martinotti, Massimo Di Giannantonio, Mauro Pettorruso, Michele Fornaro, Silvia Fraticelli대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제4호

이 간행물의 다른 논문 (16건)

Classic Studies on the Interaction of Cocaine and the Dopamine TransporterVivek Vermapp. 227-238The Gut-Brain Axis: The Missing Link in DepressionAlper Evrensel, Mehmet Emin Ceylanpp. 239-244Efficacy of Adjunctive High Frequency Repetitive Transcranial Magnetic Stimulation of Right Prefrontal Cortex in Adolescent Mania: A Randomized Sham-Controlled StudyVinod Kumar Sinha, Samir Kumar Praharaj, Vijay Pathakpp. 245-249Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive PatientsChen-Hsi Chou, I Hui Lee, Po See Chen, Yen Kuang Yang, Hui Hua Changpp. 250-255Gender Differences in the Clinical Characteristics of Psychotic Depression: Results from the CRESCEND Study김정범, 박선철, Søren Dinesen Østergaard, 김재민, 이민수, 박용천, 전태연, 임현우pp. 256-262
원문 보기